Provided by Tiger Trade Technology Pte. Ltd.

Anixa Biosciences

2.80
-0.1350-4.61%
Volume:160.28K
Turnover:454.79K
Market Cap:97.16M
PE:-9.02
High:2.93
Open:2.91
Low:2.79
Close:2.93
52wk High:5.46
52wk Low:2.32
Shares:34.76M
Float Shares:32.61M
Volume Ratio:0.95
T/O Rate:0.49%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.3100
EPS(LYR):-0.3367
ROE:-73.17%
ROA:-41.93%
PB:6.71
PE(LYR):-8.30

Loading ...

Sep 09, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 10, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Mar 12, 2026

Major Issues Report

Form 8-K - Current report
Mar 10, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Feb 09, 2026

Major Issues Report

Form 8-K - Current report
Jan 12, 2026

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Jan 12, 2026

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Dec 12, 2025

Major Issues Report

Form 8-K - Current report
Sep 27, 2025

Correspondence

Form CORRESP - Correspondence
Sep 10, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 28, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Mar 21, 2025

Major Issues Report

Form 8-K - Current report
Mar 12, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jan 10, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Jan 10, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Nov 08, 2024

Major Issues Report

Form 8-K - Current report
Sep 06, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 04, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 08, 2024

Major Issues Report

Form 8-K - Current report
May 03, 2024

Beneficial Ownership Change

Form SC 13D - General statement of acquisition of beneficial ownership